Cross Country Healthcare
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	$1.67B N/A	$2.80B 67.39%	$2.01B -28.03%	Avg: $1.40B Low: $1.32B High: $1.49B avg. -30.28%	Avg: $1.49B Low: $1.43B High: $1.57B avg. 6.40%
Net Income % change YoY	$132.00M N/A	$188.46M 42.77%	$72.63M -61.46%	Avg: $33.17M Low: $20.93M High: $45.05M avg. -54.32%	Avg: $51.02M Low: $27.67M High: $53.21M avg. 53.82%
EBITDA % change YoY	$160.47M N/A	$304.81M 89.94%	$129.33M -57.56%	Avg: $93.64M Low: $88.28M High: $99.66M avg. -27.59%	Avg: $99.64M Low: $95.73M High: $104.51M avg. 6.40%
EPS % change YoY	$3.6 N/A	$5.09 41.38%	$2.07 -59.33%	Avg: $0.96 Low: $0.59 High: $1.27 avg. -53.66%	Avg: $1.14 Low: $0.78 High: $1.5 avg. 18.84%
Operating Expenses % change YoY	$225.14M N/A	$336.78M 49.58%	$337.69M 0.27%	Avg: $233.43M Low: $220.09M High: $248.44M avg. -30.87%	Avg: $248.39M Low: $238.65M High: $260.53M avg. 6.40%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -0.25% in 2025-2026.

We have gathered data from 7 analysts. Their low estimate is 20.93M, average is 33.17M and high is 45.05M.

Wall Street analysts forecast annual average revenue growth of -11.93% in 2025-2026.

We have gathered data from 7 analysts. Their low revenue estimate is $1.32B, average is $1.40B and high is $1.49B.

Wall Street analysts forecast annual average earnings growth of -17.40% in 2025-2026.

We have gathered data from 7 analysts. Their low earnings per share estimate is $0.59, average is $0.96 and high is $1.27.

In the last twelve months analysts have been covering Cross Country Healthcare stock. The most successful analyst is Kevin Steinke.